Epidemiology of human parvovirus B19 in children with sickle cell disease

Blood

Volumn 103, Issue 2, 2004, Pages 422-427

  Smith Whitley, Kim ^a   Zhao, Huaqing ^b   Hodinka, Richard L ^b   Kwiatkowski, Janet ^b   Cecil, Renèe ^b   Cecil, Tamara ^b   Cnaan, Avital ^b   Ohene Frempong, Kwaku ^b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ACUTE CHEST SYNDROME; ACUTE SPLEEN SEQUESTRATION; ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE EXACERBATION; ERYTHROCYTE APLASIA; ERYTHROCYTE TRANSFUSION; FEMALE; FEVER; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; PAIN; PARVOVIRUS; PREVALENCE; PRIORITY JOURNAL; SICKLE CELL ANEMIA; SPLEEN DISEASE; UNITED STATES; VIRUS INFECTION;

EID: 0742316143     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-01-0069     Document Type: Article

References (28)

1. Goldstein AR, Anderson MJ, Serjeant GR. Parvovirus associated aplastic crisis in homozygous sickle cell disease. Arch Dis Child. 1987;62:585-588.
2. Serjeant GR, Serjeant BE, Thomas PW, Anderson MJ, Patou G, Pattison JR. Human parvovirus infection in homozygous sickle cell disease. Lancet. 1993;341:1237-1240.
3. Serjeant BE, Hambleton IR, Kerr S, Kilty CG, Serjeant GR. Haematological response to parvovirus B19 infection in homozygous sickle-cell disease. Lancet. 2001;358:1779-1780.
4. Mallouh AA, Qudah A. Acute splenic sequestration together with aplastic crisis caused by human parvovirus B19 in patients with sickle cell disease. J Pediatr. 1993;122:593-595.
5. Wethers DL, Grover R, Oyeku S. Aplastic crisis and acute splenic sequestration crisis. J Pediatr Hematol Oncol. 2000;22:187-188.
6. Koduri PR, Patel AR, Pinar H. Acute hepatic sequestration caused by parvovirus B19 infection in a patient with sickle cell anemia. Am J Hematol. 1994;47:250-251.
7. Lowenthal EA, Wells A, Emanuel PD, Player R, Prchal JT. Sickle cell acute chest syndrome associated with parvovirus B19 infection: case series and review. Am J Hematol. 1996;51:207-213.
8. Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med. 2000;342:1855-1865.
9. Tolaymat A, Al Mousily F, MacWilliam K, Lammert N, Freeman B. Parvovirus glomerulonephritis in a patient with sickle cell disease. Pediatr Nephrol. 1999;13:340-342.
10. Wierenga KJ, Pattison JR, Brink N, et al. Glomerulonephritis after human parvovirus infection in homozygous sickle-cell disease. Lancet. 1995;346:475-476.
11. Wierenga KJ, Serjeant BE, Serjeant GR. Cerebrovascular complications and parvovirus infection in homozygous sickle cell disease. J Pediatr. 2001;139:438-442.
12. Goldstein LJ, Strenger R, King TC, Le SC, Rogers BB. Retrospective diagnosis of sickle cellhemoglobin C disease and parvovirus infection by molecular DNA analysis of postmortem tissue. Hum Pathol. 1995;26:1375-1378.
13. Kolquist KA, Vnencak-Jones CL, Swift L, Page DL, Johnson JE, Denison MR. Fatal fat embolism syndrome in a child with undiagnosed hemoglobin S/beta+ thalassemia: a complication of acute parvovirus B19 infection. Pediatr Pathol Lab Med. 1996;16:71-82.
14. Pattison JR, Jones SE, Hodgson J, et al. Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet. 1981;1:664-665.
15. Serjeant GR, Topley JM, Mason K, et al. Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent. Lancet. 1981;2:595-597.
16. Connor E F-WG, Alfonso C, et al. A phase 1 vaccine trial with recombinant parvovirus B19 virus-like particles in seronegative healthy adult volunteers [abstract]. Blood. 1995;86:135a.
17. Gill FM, Sleeper LA, Weiner SJ, et al. Clinical events in the first decade in a cohort of infants with sickle cell disease. Blood. 1995;86:776-783.
18. Anderson MJ, Higgins PG, Davis LR, et al. Experimental parvovirus infection in man. J Infect Dis. 1985;152:257-265.
19. Klein JP, Moeschberger M. Survival Analysis: Techniques for Censored and Truncated Data. New York: Springer; 1997.
20. Rao SP, Miller ST, Cohen BJ. Transient aplastic crisis in patients with sickle cell disease. B19 parvovirus studies during a 7-year period. Am J Dis Child. 1992;146:1328-1330.
21. Cohen BJ, Buckley MM. The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol. 1988;25:151-153.
22. Kelly HA, Siebert D, Hammond R, Leydon J, Kiely P, Maskill W. The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world. Epidemiol Infect. 2000;124:449-457.
23. Anderson MJ, Davis LR, Hodgson J, et al. Occurrence of infection with a parvovirus-like agent in children with sickle cell anaemia during a two-year period. J Clin Pathol. 1982;35:744-749.
24. Mallouh AA, Qudah A. An epidemic of aplastic crisis caused by human parvovirus B19. Pediatr Infect Dis J. 1995;14:31-34.
25. Saarinen UM, Chorba TL, Tattersall P, et al. Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia. Blood. 1986;67:1411-1417.
26. Doyle S, Kerr S, O'Keeffe G, O'Carroll D, Daly P, Kilty C. Detection of parvovirus B19 IgM by antibody capture enzyme immunoassay: receiver operating characteristic analysis. J Virol Methods. 2000;90:143-152.
27. Wakamatsu C, Takakura F, Kojima E, et al. Screening of blood donors for human parvovirus B19 and characterization of the results. Vox Sang. 1999;76:14-21.
28. Jordan J, Tiangco B, Kiss J, Koch W. Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients. Vox Sang. 1998;75:97-102.